Search Results

ABBV AbbVie Inc. - Fundamental Analysis

NEUTRAL
Sign in to save Save this symbol to a watchlist or track a position.
ABBV Stock | Fundamental Analysis & Investment Insights
NYSE Healthcare Drug Manufacturers - General
Current Price Live
$219.26
Analyst Target
$245.22
+11.8% Upside
52W High
$244.81
52W Low
$164.39

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
68%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Key Strengths

High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Attractive dividend yield (3.05%) above market average
Analyst consensus supports upside with target price 11.8% above current level

Key Risks

Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
Weak liquidity position with current ratio (0.72) and quick ratio (0.47) below 1.0
Bearish insider sentiment with $11.05M in net sales and zero buys in last 6 months
AI Fair Value Estimate
Based on comprehensive analysis
$9.38
-95.7% below current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare ABBV against industry averages and similar companies

Unlock Sector Insights

See how ABBV compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning ABBV from our newsroom.

Newest → oldest

See the full ABBV analysis

Free signup • Unlock all metrics • No credit card required

TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Dashboard AI Chat Analysis Charts Profile